Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
02/1999
02/18/1999WO1998026644A3 Confirmatory assays for small molecule drugs
02/18/1999WO1998014593A3 Human telomerase catalytic subunit
02/18/1999DE19734800A1 Detection of environmental toxins in soil, composts and substrates
02/18/1999DE19733323A1 Appts. to determine rigidity of fibres esp. ceramic fibres
02/18/1999DE19731684A1 Reagent for determining plasma sample by measuring clotting time
02/18/1999CA2310622A1 Techniques and systems for analyte detection
02/18/1999CA2303274A1 Carbon monoxide and smoke detection apparatus
02/18/1999CA2300985A1 Kcnq potassium channels and methods of modulating same
02/18/1999CA2300977A1 Neutral sphingomyelinase
02/18/1999CA2300381A1 Antigens embedded in thermoplastic
02/18/1999CA2300268A1 Electrochemical reporter system for detecting analytical immunoassay and molecular biology procedures
02/18/1999CA2299630A1 Compositions that specifically bind to colorectal cancer cells and methods of using the same
02/18/1999CA2299605A1 90 human secreted proteins
02/18/1999CA2299365A1 Gas detection device and method
02/18/1999CA2299283A1 Methods of identifying biological agent compositions
02/18/1999CA2299248A1 On-line analysis of process gas during the production of ketene
02/18/1999CA2299226A1 Tango-71, tango-73, tango-74, tango-76, and tango-83 nucleic acid molecules and polypeptides
02/18/1999CA2298932A1 Linear peptides derived from antibiotic peptides, preparation and use for vectoring active substances
02/18/1999CA2298849A1 Lipoprotein-regulating medicaments
02/18/1999CA2274302A1 Lsr receptor, activity, cloning, and uses for diagnosing, preventing and/or treating obesity and related risks or complications
02/17/1999EP0897114A2 A method of identifying agonist and antagonists for tumor necrosis related receptors TR1 and TR2
02/17/1999EP0897015A2 Method for evaluating drug metabolism and reagent compositions therefor
02/17/1999EP0897011A2 Novel arginine deiminase
02/17/1999EP0897008A2 His5
02/17/1999EP0897007A2 MraY transferase
02/17/1999EP0897004A2 Histidyl tRNA synthetase from Streptococcus pneumoniae (hisS)
02/17/1999EP0896672A1 Process and device for measuring blood platelet aggregation or blood coagulation
02/17/1999EP0896671A1 Apparatus for measuring a gas value
02/17/1999EP0896670A1 Process and device for determining the oxidisable substance content of aqueous liquids
02/17/1999EP0896669A1 Measuring chlorine concentration
02/17/1999EP0896667A1 Process and device for detecting oxidable and/or reducible gasses in air
02/17/1999EP0896665A1 Image recording system for evaluating analytical test elements
02/17/1999EP0896664A1 Reflection measuring device and method for determining quality properties of items, particularly fat-containing items
02/17/1999EP0896663A1 Spectral information transmission through communication optical fibers
02/17/1999EP0896631A1 METHOD FOR SIMULTANEOUS DETECTION OF MULTIPLE FLUOROPHORES FOR $i(IN SITU) HYBRIDIZATION
02/17/1999EP0896623A1 Immunity to trypanosomatids species
02/17/1999EP0896622A1 Chemokine alpha 2
02/17/1999EP0896615A1 Peptide from soluble form of acetylcholinesterase, active as a calcium channel modulator
02/17/1999EP0896586A1 ErbB3 ANTIBODIES
02/17/1999EP0896584A2 BIOLOGICALLY ACTIVE PROTEIN (COLLAGEN FRAGMENT HF-COLL-18/514cf) FOR INHIBITING THE GROWTH OF TUMOURS AND CAPILLARY PROFILERATIONS
02/17/1999EP0896582A1 Non-dendritic backbone peptide carrier
02/17/1999CN1208465A Method of determining the hepatic status of an individual, including a liver transplant recipient
02/17/1999CN1208464A Device and methods for using centripetal acceleration to drive fluid movement in a microfluidics system with on-board informatics
02/17/1999CN1208441A A method for high-sensitive silver staining
02/17/1999CN1208436A Novel polypeptide originating in hemophilus paragallinarum and process for producing the same
02/17/1999CN1208399A Water soluble tri-substituted 1,2-dioxetane compounds having increased storage stability, synthetic processes and intermediates
02/17/1999CN1042172C Method of continuous steps immunoassays and its automatic measuring apparatus
02/16/1999US5873052 Alignment-based similarity scoring methods for quantifying the differences between related biopolymer sequences
02/16/1999US5872860 Calibration cassette for use in calibrating an automated agglutination reaction analyzing system
02/16/1999US5872713 For detecting the presence of an analyte in a sample
02/16/1999US5872447 Time domain reflectometry.
02/16/1999US5872314 Method and apparatus for measuring characteristics of meat
02/16/1999US5872305 Method for preparing a test gas stream
02/16/1999US5872231 Nucleic acids encoding merosin
02/16/1999US5872226 Fibroblast growth factor homologous factor-1 (FHF-1)
02/16/1999US5872224 Boronic compound complexing reagents and highly stable complexes
02/16/1999US5872221 Capable of binding epitopes of pthrp and a kit for the detection of pthrp or fragments thereof comprising one or more antibody reagents capable of binding to epitopes of pthrp
02/16/1999US5872220 Antibodies to insulin-like growth factor binding protein IGFBP-6
02/16/1999US5872219 Antibodies drawn to the eps15 substrate for epidermal growth factor receptor kinase
02/16/1999US5872218 Monoclonal antibodies
02/16/1999US5872217 Antibodies which specifically bind a cancer related antigen
02/16/1999US5872213 Purified protein, designated ini-1, capable of interacting with the hiv-1 integrase
02/16/1999US5872212 Pesticidal proteins and strains
02/16/1999US5872209 Artificial recombinant substrate (rAGG 1) and native aggrecan to determine the proteolytic activity of `aggrecanase` in cell culture systems
02/16/1999US5872095 IL-1 receptor antagonists medicaments
02/16/1999US5872015 Molecular diversity screening method
02/16/1999US5872014 Assay for multi-drug resistance
02/16/1999US5872013 Universally applicable detection system based on ultra small colloidal metal particles
02/16/1999US5872012 Protamine-reactive IGM antibodies
02/16/1999US5872009 Method for measuring bilirubin
02/16/1999US5872008 Methods for diagnosing pre-menstrual syndrome
02/16/1999US5872006 Family of MAP2 protein kinases
02/16/1999US5872003 DNA sequencing by mass spectrometry via exonuclease degradation
02/16/1999US5871998 Gene expression in transformed eukaryotic host cell; genetic engineering
02/16/1999US5871996 First agent comprising isolated virus having reverse transcriptase activity, second agent distinct from first, comprising nucleotides; both agents associated with multiple sclerosis and purifiable from viral isolate pol-2 and ms7pg
02/16/1999US5871973 Cell division regulators
02/16/1999US5871963 Nucleotide sequences
02/16/1999US5871950 Methods of treating autoimmune diseases and transplantation rejection
02/16/1999US5871947 Measuring ratio of activity of erythrocyte pyrimidine 5'-nucleotidase and its isozyme deoxyribonucleotidase; evaluating; detecting toxic lead levels in children
02/16/1999US5871946 Method for determining activity of enzymes in metabolically active whole cells
02/16/1999US5871945 Modulators of anchoring protein function
02/16/1999US5871942 Immunoassay for H. pylori in fecal specimens
02/16/1999US5871941 Method of testing expression of CA125 antigen in cultured ovarian surface epithelial cells to identify and monitor individuals having a predisposition to develop ovarian cancer
02/16/1999US5871939 Agents and method for identifying insects
02/16/1999US5871938 Detection of protease, incubation, bonding to dna and antibodies
02/16/1999US5871937 Complexing; binding gramnegative endotoxin secreted in gastrointestinal infections
02/16/1999US5871934 Screening methods using cytokine suppressive anti-inflammatory drug (CSAID) binding proteins
02/16/1999US5871933 Diagnosing, screening, and confirming infection with accuracy; vaccines
02/16/1999US5871917 Identification of differentially methylated and mutated nucleic acids
02/16/1999US5871913 Forms a complex with a human immunodeficiency virus envelope glycoprotein
02/16/1999US5871911 Annealing target and pilot nucleic acids to form duplex; exposing to polymerase; genetic engineering
02/16/1999US5871909 Human cellular retinoic acid binding protein I and II DNA and methods of use
02/16/1999US5871907 Methods for producing members of specific binding pairs
02/16/1999US5871905 Microparticle-based immunoassay using bile acid or salt; accuracy
02/16/1999US5871904 Immunassay of non-A, non-B hepatitis virus-related antigens, monoclonal antibodies for use therein, and hybridomas producing the antibodies
02/16/1999US5871901 Assay for inhibitors of DP-1 and other DP proteins
02/16/1999US5871804 Flourescent lipid reagent
02/16/1999US5871745 Isolated virus having reverse transcriptase activity, second agent distinct from first, comprising nucleotides; both agents associated with multiple sclerosis and purifiable from viral isolate pol-2 and ms7pg
02/16/1999US5871740 Genetic engineering with proteins, antiinflammatory agents and gene expression
02/16/1999US5871737 Methods for treating a fibrin encapsulated tumor using a fibrin specific monoclonal antibody and compositions used therein